Related Articles
High mobility group box 1 and kidney diseases (Review)
HMGB1 induces lung fibroblast to myofibroblast differentiation through NF‑κB‑mediated TGF‑β1 release
Effect of NF‑κB inhibitor on high‑mobility group protein B1 expression in a COPD rat model
Thalidomide decreases high glucose‑induced extracellular matrix protein synthesis in mesangial cells via the AMPK pathway
The HMGB1‑RAGE/TLR‑TNF‑α signaling pathway may contribute to kidney injury induced by hypoxia